Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: Can we predict earlier?

被引:33
作者
Chong, Charing Ching-Ning [1 ]
Lee, Kit-Fai [1 ]
Ip, Philip Ching-Tak [1 ]
Wong, Jeff Siu-Wang [1 ]
Cheung, Sunny Yue-Sun [1 ]
Wong, John [1 ]
Ho, Suzanne C. [2 ]
Lai, Paul Bo-San [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Special Adm Reg, Dept Surg, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Special Adm Reg, Dept Community & Family Med, Hong Kong, Hong Kong, Peoples R China
来源
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND | 2012年 / 10卷 / 05期
关键词
Hepatocellular carcinoma; Hepatectomy; Recurrence; Predictors; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; LONG-TERM SURVIVAL; INTRAHEPATIC RECURRENCE; RISK-FACTORS; LIVER RESECTION; CURATIVE RESECTION; TRANSARTERIAL CHEMOEMBOLIZATION; PROGNOSTIC-FACTORS; SPONTANEOUS RUPTURE; NONCIRRHOTIC LIVER;
D O I
10.1016/j.surge.2011.07.004
中图分类号
R61 [外科手术学];
学科分类号
摘要
Backgrounds and purpose: To determine the predictors for recurrence in patients receiving curative hepatectomy for hepatocellular carcinoma (HCC). Methods: From January 2001 to July 2007, all patients having hepatectomy for first occurrence HCC with curative intent were identified from a prospectively collected database. Prognostic factors for recurrence and survival after resection were analyzed. Results: A total of 235 patients were included. With a median follow-up of 50.2 (0.07-125.1) months, the recurrence rate was 57.0%. The 1-, 3-, and 5-year overall survival rates were 83.9%, 66.0%, and 58.1% respectively. Multivariate analysis demonstrated that multi-focal lesions (HR: 2.93, P < 0.001), alpha-fetoprotein (AFP) level greater than 100 ng/ml (HR: 1.74, P = 0.002) and history of tumor rupture (HR: 2.84, P = 0.003) were independent risk factors for recurrence of HCC after hepatectomy. Conclusions: Predictors for HCC recurrence can be identified before operation. These important parameters should be considered before and after contemplating curative resection for HCC patients and for risk stratification in future clinical trials for neoadjuvant or post-resection adjuvant therapy. The possible use of neoadjuvant or adjuvant treatment to improve survival should be addressed by further trials. Crown Copyright (c) 2011 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:260 / 266
页数:7
相关论文
共 37 条
[1]  
ARII S, 1992, CANCER, V69, P913, DOI 10.1002/1097-0142(19920215)69:4<913::AID-CNCR2820690413>3.0.CO
[2]  
2-T
[3]   Predictors and patterns of recurrence after resection of hepatocellular carcinoma [J].
Cha, C ;
Fong, YM ;
Jarnagin, WR ;
Blumgart, LH ;
DeMatteo, RP .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (05) :753-758
[4]   Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation [J].
Chapman, William C. ;
Doyle, M. B. Majella ;
Stuart, Jourdan E. ;
Vachharajani, Neeta ;
Crippin, Jeffrey S. ;
Anderson, Christopher D. ;
Lowell, Jeffrey A. ;
Shenoy, Surendra ;
Darcy, Michael D. ;
Brown, Daniel B. .
ANNALS OF SURGERY, 2008, 248 (04) :617-624
[5]   Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma [J].
Chen, Xiao-ping ;
Hu, Dao-yu ;
Zhang, Zhi-wei ;
Zhang, Bi-xiang ;
Chen, Yi-fa ;
Zhang, Wan-guang ;
Qiu, Fa-zu .
DIGESTIVE SURGERY, 2007, 24 (03) :208-213
[6]   Resection of hepatocellular carcinoma in noncirrhotic liver: Analysis of risk factors for survival [J].
Dupont-Bierre, E ;
Compagnon, P ;
Raoul, JL ;
Fayet, G ;
de Lajarte-Thirouard, AS ;
Boudjema, K .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 201 (05) :663-670
[7]   Liver resection for hepatocellular carcinoma on cirrhosis - Univariate and multivariate analysis of risk factors for intrahepatic recurrence [J].
Ercolani, G ;
Grazi, GL ;
Ravaioli, M ;
Del Gaudio, M ;
Gardini, A ;
Cescon, M ;
Varotti, G ;
Cetta, F ;
Cavallari, A .
ANNALS OF SURGERY, 2003, 237 (04) :536-543
[8]   Role of transarterial chemoembolization before liver resection for hepatocarcinoma [J].
Gerunda, GE ;
Neri, D ;
Merenda, R ;
Barbazza, F ;
Zangrandi, F ;
Meduri, F ;
Bisello, M ;
Valmasoni, M ;
Gangemi, A ;
Faccioli, AM .
LIVER TRANSPLANTATION, 2000, 6 (05) :619-626
[9]  
GLOBOSCAN, 2008, CANC INC MORT WORLDW
[10]   Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value [J].
Grazi, GL ;
Ercolani, G ;
Pierangeli, F ;
Del Gaudio, M ;
Cescon, M ;
Cavallari, A ;
Mazziotti, A .
ANNALS OF SURGERY, 2001, 234 (01) :71-78